(Refiles to remove extraneous link in paragraph 1) April 30 (Reuters) - Dr Lal Path Labs reported a 15.5% drop in fourth-quarter profit on Thursday, hurt by higher tax expenses. Here are some details: ...
This article first appeared on GuruFocus. Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) is set to release its Q4 2026 earnings on April 30, 2026. The consensus estimate for Q4 2026 revenue is $6.73 billion, ...
ET Now on MSN
Dr Lal Path Labs dividend 2026: Rs 4 per share payout in Q4 results FY26 - Record date on June 26
Dr Lal Path Labs Dividend 2026: The BSE 500 company on April 30 announced its Q4 quarterly earnings for financial year ...
Earnings call Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, ...
April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...
Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
Bengaluru: Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India's new labour code, despite strong demand for its bundled test packages.
Get all latest & breaking news on Dr Lal Path Labs. Watch videos, top stories and articles on Dr Lal Path Labs at moneycontrol.com.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results